bioMérieux revenue and financials

BIM · Euronext Paris · EUR

Compare bioMérieux
€91.30Change from previous close: +0.16%Absolute change: +€0.15

Close · November 20, 2026

In the fiscal year ended December 2025, bioMérieux reported revenue of €4.07B (+2.26% year over year). Net income was €397.5M, a net margin of 9.8%.

Annual revenue · 2025: €4.07B
  1. €2.1B2016
  2. €2.29B2017
  3. €2.42B2018
  4. €2.67B2019
  5. €3.12B2020
  6. €3.38B2021
  7. €3.59B2022
  8. €3.67B2023
  9. €3.98B2024
  10. €4.07B2025

Fiscal year ending in December. Sources and method on the page How we analyse stocks.

At a glance

Revenue growth
+2.26%
2025 vs 2024
Net income growth
−8.03%
2025 vs 2024
Net margin
9.8%
2024: 10.9%

How bioMérieux is changing

Calculated from the annual statements; each fiscal year is labelled with the year it ends.

Financial data

Amounts in millions of EUR; per-share values in EUR; shares in millions.

Income statement · Annual
Item2025202420232022202120202019201820172016
Total revenue4,0703,9803,6753,5893,3763,1182,6752,4212,2882,103
Cost of revenue1,7611,7651,6171,5801,3751,3651,2081,1191,0761,003
Gross profit2,3092,2152,0572,0092,0011,7541,4671,3021,2121,101
Selling, general and administrative1,1111,0981,021955816789750643604570
Research and development507492460447386399374327304272
Operating income695638569613814613388364335298
EBIT695638569613814613388364335298
EBITDA1,1309488588531,005797551519475439
Interest expense15.816.015.84.19.124.920.119.716.117.1
Pre-tax income526579437581774524348321292259
Income tax12915411514017612277.865.154.579.8
Net income398432358452601404273257238179
Net income to common shareholders398432358452601404273257238179
Basic EPS3.373.673.033.845.083.422.312.182.021.51
Diluted EPS3.343.643.013.825.063.412.302.172.011.51
Average shares (basic)118118118118118118118118118118
Average shares (diluted)119119119118119119119118118118
Dividend per share0.980.900.850.850.850.620.190.350.340.33

Companies in the group: same industry, similar size